Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia;Seroprevalencia de anticuerpos antiparvovirus B19 en una muestra de donantes de sangre en Galicia

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 16, Issue 1, 1998, Pages 25-27

  Rebón, Montserrat Mata ^a   Bartolomé Husson, Carolina ^a   Hermida, Isabel Bernárdez ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Antibodies; Blood donors; ELISA; Parvovirus B19; Seroprevalence

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; SEROPREVALENCE; VIRUS INFECTION;

EID: 0031907068     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.111/J.0213-005X     Document Type: Article

References (23)

1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1: 72-73.
2. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114-117.
3. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CLR et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983; 1: 1.378.
4. Nikkari S, Lauukkainen R, Möttönen T, Meurman O, Hannonen P, Skurnik M et al. Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis 1994; 53: 106-111.
5. Kelleher JF, Luban NLC, Mortimer PP, Kamimura T. Human serum «parvovirus»: a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr 1983; 102: 720-722.
6. Gyllensten K, Sönnerborg A, Jorup-Rönström C, Halavarsson M, Yun Z. Parvovirus B19 infection in HIV-1 infected patients with anemia. Infection 1994; 22: 356-358.
7. Gratacós E, Torres PJ, Vidal J, Antolín E, Costa J, Jiménez de Anta MT et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995; 171: 1.360-1.363.
8. Corsi BO, Azzi A, Morfini M, Fanci R, Ferrini RP. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165-170.
9. Kerr JR. Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis 1996; 15: 10-29.
10. Chapman MS, Rossmann MG. Structure, sequence and function correlations among parvoviruses. Virology 1993; 194: 491-508.
11. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM et al. Experimental parvoviral infection in humans. J infect Dis 1985; 152: 257-265.
12. Fridell E, Cohen BJ, Wahren B. Evaluation of a synthetic-peptide enzyme-linked immnosorbent assay for inmunoglobulin M to human parvovirus B19. J Clin Microbiol 1991; 29: 1.376-1.381.
13. Matsunaga Y, Takeda N, Yamazaki S, Kamata K, Kurosawa D. Seroepidemiology of human parvovirus B19 uring recombinant VP1 + VP2 particle antigen. Kansenshogaku Zasshi 1995; 69: 1.371-1.375.
14. Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y. Human parvovirus B19 infection in blood donors. Vox Sang 1995; 69: 206-212.
15. Rollag H, Patou G, Pattison JR, Degre M, Evensen SA, Froland SS et al. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donors pools. Scand J Infect Dis 1991; 23: 675-679.
16. Wiersbitzky S, Schwarz TF, Bruns R, Jager G, Bittner S, Weidemann H et al. Seroprevalence of human parvovirus B19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population. Kinderarztl Prax 1990; 58: 185-189.
17. Schwarz TF, Gurtler LG, Zoulek G, Deinhardt F, Roggendorf M. Seroprevalence of human parvovirus B19 infection in Sao Tome and Principle, Malawi and Mascarene Islands. Int J Med Microbiol 1989; 271: 231-236.
18. Grosse-Bley A, Eis-Hubinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF et al. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 1994; 72: 503-507.
19. Anderson LJ. Human parvoviruses. J Infect Dis 1990; 161: 603-608.
20. García-Tapia AM, Fernández-Gutiérrez del Álamo C, Girón JA, Mira J, De la Rubia F, Martínez-Rodríguez A et al. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cádiz, Spain. Clin Infect Dis 1995; 21: 1.424-1.430.
21. Sodja I, Mrazova M, Smelhausova M, Kotrbova K, Pazdiora P, Bruj J et al. Seroprevalence of IgG antibodies against parvovirus B19 in the population of Czech Republic. Epidemiol Mikrobiol Imunol 1995; 44: 171-174.
22. Sato H, Takakura F, Kojima E, Fukada K, Okochi K, Maeda Y. Screening of blood donors for human parvovirus B19. Lancet 1995; 346: 1.237-1.238.
23. Cohen B, Millar A, Schwind P. Screening blood donations for parvovirus B19. Lancet 1995; 346: 1.361.